Related Experiment Video
Updated: Dec 18, 2025
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Revascularization in cardiogenic shock
Anne Freund1,2, Steffen Desch3,4, Holger Thiele3
1Department of Internal Medicine/Cardiology, Heart Center Leipzig at University of Leipzig, Strümpellstr. 39, 04289, Leipzig, Germany. anne.freund@medizin.uni-leipzig.de.
Insights
Early revascularization improves survival in acute myocardial infarction patients with cardiogenic shock. Culprit-lesion-only PCI is favored over immediate multi-vessel PCI in select cases, according to the CULPRIT-SHOCK trial.
Area of Science:
- Cardiology
- Interventional Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock complicates approximately 10% of acute myocardial infarctions.
- Early revascularization is the cornerstone of treatment for infarct-related cardiogenic shock.
- Percutaneous coronary intervention (PCI) is the primary revascularization method.
Purpose of the Study:
- To summarize current evidence on the management of cardiogenic shock post-myocardial infarction.
- To highlight the role of early revascularization and PCI.
- To identify knowledge gaps in anticoagulation, antiplatelet therapy, and mechanical circulatory support.
Main Methods:
- Review of randomized studies and clinical guidelines.
- Emphasis on findings from the CULPRIT-SHOCK trial.
- Discussion of Heart Team consultation for complex cases.
Main Results:
- Randomized trials demonstrate improved survival with early revascularization in cardiogenic shock.
- The CULPRIT-SHOCK study showed a survival benefit for culprit-lesion-only PCI versus immediate multi-vessel PCI.
- Limited data exist on optimal anticoagulation, antiplatelet therapy, and mechanical support.
Conclusions:
- Early revascularization, primarily via PCI, is crucial for infarct-related cardiogenic shock.
- Culprit-lesion-only PCI offers a survival advantage in specific patient groups.
- Further research is needed on adjunctive therapies and mechanical support in cardiogenic shock.
Abstract:
Approximately 10% of patients with acute myocardial infarction develop cardiogenic shock. Randomized studies have shown a significant improvement in survival with early revascularization, which now represents the most important cornerstone in the treatment of infarct-related cardiogenic shock. In the vast majority of cases, this is achieved by percutaneous coronary intervention (PCI). In cases of complex coronary anatomy or mechanical complications, the Heart Team should be consulted promptly. The randomized CULPRIT-SHOCK study showed a survival advantage for patients with multivessel coronary artery disease and a percutaneous revascularization strategy who were treated by culprit-lesion-only PCI compared with immediate multivessel PCI. There are currently few data on anticoagulation and antiplatelet therapy in cardiogenic shock as well as on active mechanical circulatory support in this setting.
Related Concept Videos
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
01:24Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:17Aortic Regurgitation IV: Nursing Management
01:21Cardiopulmonary Resuscitation I: Adult
01:27Coronary Artery Disease V: Interprofessional Care